β受体阻滞剂对无左心室收缩功能障碍的心肌梗死患者真的重要吗？对萨比娜等人的评论。β受体阻滞剂在心肌梗死且左心室射血功能保留的患者中的应用：随机对照试验的系统评价和荟萃分析。2025年，第150期。
Do Beta-Blockers Really Matter in Patients with Myocardial Infarction Without Left Ventricular Systolic Dysfunction? Comment on Sabina et al. Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. . 2025, , 150.
作者信息
Acerbo Vincenzo, Cesaro Arturo, Calabrò Paolo
机构信息
Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", 80131 Naples, Italy.
Division of Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", 81100 Caserta, Italy.
出版信息
J Clin Med. 2025 Mar 26;14(7):2247. doi: 10.3390/jcm14072247.
Abstract
Beta-blockers represent a key treatment pillar for reducing mortality and morbidity in patients with myocardial infarction (MI) and stable heart failure with a reduced ejection fraction (HFrEF) [...].
摘要
β受体阻滞剂是降低心肌梗死（MI）和射血分数降低的稳定心力衰竭（HFrEF）患者死亡率和发病率的关键治疗支柱[……]。
Zotero 插件